Loading patent…
AssigneeSuperlab Far East Limited
InventorGuangwen WEI
Estimating the term…
The invention provides a method and/or composition for the treatment of bone cancer including primary bone cancer and secondary bone cancer, breast cancer, skin cancer, nasopharyngeal carcinoma, oral cancer, vulva cancer, prostate cancer, cervical cancer, melanoma including melanocarcinoma by percutaneous and/or transmucosal administration of the interferon. Further, the invention provides a method and/or composition for the treatment of skin, subcutaneous, mucosal and/or submucosal primary cancer and cancer metastatic lesions by percutaneous and/or transmucosal administration of the interferon, especially a method and/or composition for the treatment of bone cancer pain including pain resulted by secondary bone cancer.
1-197. (canceled)
A method of treating skin cancer, subcutaneous cancer, mucosal carcinoma, submucosal carcinoma, and/or bone pain associated with cancer in a subject, comprising administering to the subject an effective amount of an anti-cancer interferon, wherein the interferon comprises an amino acid sequence of SEQ ID NO:
A method of treating both a primary tumor and a secondary cancer that has metastasized from the primary tumor in a subject, comprising administering to the subject an effective amount of an anti-cancer interferon, wherein the interferon comprises an amino acid sequence of SEQ ID NO:
Dependencies are inferred from the claim text.